Analyzing the Metrics of Stocks Advertised on CNBC
Looking into some of the companies advertised on CNBC shows their riskiness for stock investors.
Charles Rotblut
| SECTOR | INDUSTRY |
| Health Care | Health Care Equipment & Supplies |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Looking into some of the companies advertised on CNBC shows their riskiness for stock investors.
Charles Rotblut
Jenna Brashear
Jack Gilleland
Jenna Brashear
Cynthia McLaughlin
| Share Statistics | NXL | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $1.2 | $370.8 | 1% |
|
| Shares Out (Mil) | 0.8 | 41.4 | 4% |
|
| Institutional Ownership | 57.7% | 82.9% | 38% |
|
| Float (Mil) | 0.7 | 37.4 | 2% |
|
| Beta | na | 0.89 | na |
|
| Avg Daily Volume (000s) | 20 | 323 | 21% |
|
| Price Change (52-week) |
(95.6%) | 57.7% | 3% |
|
| Growth | NXL | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 8.4% | 11.8% | 52% |
|
| Net Income (5yr) | (19.3%) | (5.7%) | 21% |
|
| EPS (5yr) | 12.0% | 10.6% | 51 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | 2.9% | (15.8%) | 66% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 1 | 1 | 1 | |
| Current EPS | ($2.340) | ($11.420) | ($7.550) | |
| Month Ago EPS | ($2.340) | ($11.420) | ($7.550) | |
| # Rev Up | 1 | 0 | na | |
| # Rev Down | 0 | 1 | na | |
| Three Months Ago EPS | ($2.700) | ($11.400) | ($9.300) | |
| Year/Year Chg | (31.8%) | (24.1%) | na | |
| Financials | NXL | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $0 | $125 | 0% |
|
| Net Income (TTM) (Mil) | ($9) | ($9) | 29% |
|
| EPS (TTM) | ($13.557) | ($0.300) | 4% |
|
| Operating Cash Flow (TTM) (Mil) | ($6) | ($1) | 24% |
|
| Net Cash Flow (TTM) (Mil) | $0 | $2 | 46% |
|
| Long-Term Debt (Q1) (Mil) | $0 | $21 | 13% |
|
| Enterprise Value (Q1) (Mil) | $2 | $381 | 5% |
|
| Valuation | NXL | Industry Median |
Percentile (All Stocks) |
|
| P/B | 4.24 | 2.52 | 78% |
|
| P/E | na | 26.1 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.3 | na |
|
| Ratios | NXL | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 82.4% | 59.5% | 90% |
|
| Net Margin | na | (4.5%) | na |
|
| ROA | (222.9%) | (10.1%) | 1% |
|
| ROE | (372.6%) | (8.5%) | 2% |
|
| Liabilities to Assets | 92.0% | 45.8% | 89% |
|
| F-Score | 3 | 4 | 18% |
|
Nexalin Technology, Inc. did not pass any screens on 11/18/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors